#1: Caffeine's cardiac impact, cardiologists' financial ties, hidden CAD dangers, and sotatercept news

#1: Caffeine's cardiac impact, cardiologists' financial ties, hidden CAD dangers, and sotatercept news

Welcome to another exciting podcast episode, where we dive into the latest cardiovascular research!

Join us as we discuss four fascinating studies:

STUDY #1: Discover how subclinical coronary atherosclerosis detected by computed tomographic angiography (CTA) can pose a significant risk for myocardial infarction (MI) in asymptomatic middle-aged men and women in a Danish cohort.

Fuchs A et al. Subclinical coronary atherosclerosis and risk for myocardial infarction in a Danish cohort: A prospective observational cohort study. Ann Intern Med 2023 Mar 28; [e-pub]. (https://doi.org/10.7326/M22-3027)

STUDY #2: We'll examine the Open Payments Program (OPP) data, revealing trends in industry payments to cardiologists from 2014 to 2019, including the necessity for transparency.

Zhang R et al. Trends in industry payments to cardiologists from 2014 to 2019. Circ Cardiovasc Qual Outcomes 2023 Mar 17; [e-pub]. (https://doi.org/10.1161/CIRCOUTCOMES.122.009820)

STUDY #3: In this randomized case-crossover study, we'll explore whether caffeinated coffee affects premature atrial contractions (PACs) and ventricular contractions (PVCs) in healthy adults.

Marcus GM et al. Acute effects of coffee consumption on health among ambulatory adults. N Engl J Med 2023 Mar 23; 388:1092. (https://doi.org/10.1056/NEJMoa2204737)

STUDY #4: Lastly, we'll discuss a phase 3 trial of sotatercept, a potential new class of therapy for pulmonary arterial hypertension (PAH), focusing on its effects on 6-minute walk distance and other secondary endpoints.

Hoeper MM et al. Phase 3 trial of sotatercept for treatment of pulmonary arterial hypertension. N Engl J Med 2023 Mar 6; [e-pub]. (https://doi.org/10.1056/NEJMoa2213558)

This episode promises to be a wealth of knowledge and insights into cardiovascular health. So, get comfortable, grab your headphones, and let's dive into these captivating studies to uncover the secrets to a healthier heart. Enhance your understanding and make a difference in patients' lives. See you there!

For shownotes, visit us at https://www.medmastery.com/podcasts/cardiology-podcast.

Tämä jakso on lisätty Podme-palveluun avoimen RSS-syötteen kautta eikä se ole Podmen omaa tuotantoa. Siksi jakso saattaa sisältää mainontaa.

Jaksot(25)

#25: Influenza and myocardial infarction, fasting protocols for cath lab procedures, anticoagulation therapy and transcatheter aortic-valve replacement

#25: Influenza and myocardial infarction, fasting protocols for cath lab procedures, anticoagulation therapy and transcatheter aortic-valve replacement

In today's episode of Cardiology Digest, we look at three recent research papers that can impact your clinical practice. They're from NEJM Evidence, the European Heart Journal, and The New England Jou...

8 Loka 202410min

#24: Patient selection and antiplatelet therapy for percutaneous coronary intervention (PCI), the best anticoagulants for patients with atrial fibrillation

#24: Patient selection and antiplatelet therapy for percutaneous coronary intervention (PCI), the best anticoagulants for patients with atrial fibrillation

In this episode of Medmastery's Cardiology Digest, we dive into three groundbreaking studies that are set to reshape our understanding and approach to cardiology. STUDY #1: First, we discuss a landmar...

24 Syys 202411min

#23: Edoxaban dosage and atrial fibrillation, invasive vs. noninvasive treatment of NSTEMI, chelation therapy for coronary artery disease

#23: Edoxaban dosage and atrial fibrillation, invasive vs. noninvasive treatment of NSTEMI, chelation therapy for coronary artery disease

Stay ahead with the newest cardiology research findings that could change your clinical practice! STUDY #1: First up, we explore new data on edoxaban dosage for older patients with atrial fibrillation...

10 Syys 202410min

#22: Heart failure & rapid uptitration of neurohormonal blockade, home treatment for acute pulmonary embolism, cardiovascular outcomes after bariatric surgery for weight loss

#22: Heart failure & rapid uptitration of neurohormonal blockade, home treatment for acute pulmonary embolism, cardiovascular outcomes after bariatric surgery for weight loss

Welcome to the latest episode of Medmastery's Cardiology Digest, where In less than 15 minutes we'll get you up to date on breakthrough studies and advancements in cardiology that can impact your clin...

27 Elo 202412min

#21: Semaglutide and blindness, antihypertensive medications and eczematous dermatitis, the new PREVENT cardiovascular risk calculator

#21: Semaglutide and blindness, antihypertensive medications and eczematous dermatitis, the new PREVENT cardiovascular risk calculator

This week, we have three compelling research papers that are sure to expand your clinical acumen. STUDY #1: We explore the debate surrounding the new PREVENT calculator's impact on predictions of 10-y...

13 Elo 202412min

#20: Comparing 2 cryoballoons for ablation of paroxysmal atrial fibrillation, a high-risk subpopulation for transcatheter aortic valve replacement, hypertensive disorders in pregnancy

#20: Comparing 2 cryoballoons for ablation of paroxysmal atrial fibrillation, a high-risk subpopulation for transcatheter aortic valve replacement, hypertensive disorders in pregnancy

In this episode of Cardiology Digest, we dive into top journals like JAMA Cardiology to bring you three of the most compelling recent research papers from the field of cardiology. STUDY #1: First, see...

30 Heinä 202412min

#19:  Coffee's impact on blood pressure, safety of carotid artery stenting in the real world, transcatheter aortic-valve replacement in patients with coronary artery disease

#19: Coffee's impact on blood pressure, safety of carotid artery stenting in the real world, transcatheter aortic-valve replacement in patients with coronary artery disease

Ready to dig into the latest cardiology research? In less than 15 minutes, we'll give you the low-down on three new studies that'll help you in clinical practice. STUDY #1: First, we explore safety ou...

16 Heinä 202410min

#18: CHA2DS2-VASc scoring and anticoagulation for silent atrial fibrillation, race and renin-angiotensin system inhibition in HFrEF, V142I transthyretin gene variant and cardiovascular health

#18: CHA2DS2-VASc scoring and anticoagulation for silent atrial fibrillation, race and renin-angiotensin system inhibition in HFrEF, V142I transthyretin gene variant and cardiovascular health

In less than 15 minutes, Medmastery's Cardiology Digest will give you the low-down on some of the most compelling studies in cardiology that clinicians with an interest in cardiovascular health need t...

2 Heinä 202412min

Suosittua kategoriassa Tiede

rss-mita-tulisi-tietaa
utelias-mieli
rss-hereilla
tiedekulma-podcast
hippokrateen-vastaanotolla
rss-kasvikutsut
university-of-eastern-finland
docemilia
rss-ruoka-murroksessa
rss-poliisin-mieli
rss-duodecim-lehti
vinkista-vihia
rss-jyvaskylan-yliopisto
rss-kasvatuspsykologiaa-kaikille
rss-yleislaakarin-sydanaanet
rss-lapsuuden-rakentajat-podcast
radio-antro
rss-ilmasto-kriisissa
rss-lihavuudesta-podcast
rss-tiedetta-vai-tarinaa